The FDA expands use of linaclotide to children as young as age 7 years with irritable bowel syndrome with constipation (IBS-C ...

Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...

The FDA has updated the label indication for linaclotide capsules for the treatment of irritable bowel syndrome with ...

Two open-label extension studies show that the FcRn blocker nipocalimab has durable efficacy and sustained symptom control ...

FDA approves IBS drug for children, Linzess, to treat pediatric IBS-C in patients ages 7 and older with proven safety and efficacy.

The FDA has approved linaclotide (Linzess) capsules for pediatric patients 7 years and older with irritable bowel syndrome with constipation, according to a Nov. 5 news release. Linzess is the first ...

A Listeria outbreak has claimed the lives of at least six people and hospitalized dozens more, including two in Louisiana.

The family of two-year-old De'Markus Jeremiah Page has filed a lawsuit against Shands Children's Hospital after his death, ...

Aziayh Scott, 24, has pleaded not guilty to manslaughter in connection with the death of 22-month old Quayshawn Wilson. The ...

A California fruit company has recalled conventional yellow and white peaches sold nationwide at Trader Joe's, Costco, Target ...

We review the current state of influenza, from its virology and public health impact to the limitations of vaccination and ...